Assessing Treatment Response in Metastatic Breast Cancer

被引：0

作者：

Shachar, Shlomit Strulov ^{[1
,2
]}

Muss, Hyman B. ^{[1
]}

机构：

[1] Univ N Carolina, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[2] Rambam Hlth Care Campus, Div Oncogen, Haifa, Israel

来源：

AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY | 2016年 / 12卷 / 06期

关键词：

metastatic breast cancer; treatment; response; imaging;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Metastatic breast cancer remains incurable, and most patients receive endocrine therapy, chemotherapy, and/or biologic therapy over the course of their treatment. In spite of a plethora of new approved agents there have been no convincing major advances in the overall survival of patients with metastatic breast cancer, except for those with Human Epidermal Growth Factor Receptor-2 positive tumors. The goals of treatment in the metastatic setting are control or palliation of symptoms and maintaining the highest quality of life. In the last several years there have been major advances in imaging and new technologies, such as the measurement of circulating tumor cells, which have made assessment of treatment response more complicated. In this context, outside of a clinical trial, we will share our recommendations for addressing the challenge of assessing treatment response in patients with metastatic breast cancer.

引用

页码：6 / 10

页数：5

共 32 条

[1] 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer [J].

Avril, Stefanie ;

Muzic, Raymond F., Jr. ;

Plecha, Donna ;

Traughber, Bryan J. ;

Vinayak, Shaveta ;

Avril, Norbert .

JOURNAL OF NUCLEAR MEDICINE, 2016, 57 :34S-39S

[2] Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer [J].

Baselga, Jose ;

Campone, Mario ;

Piccart, Martine ;

Burris, Howard A., III ;

Rugo, Hope S. ;

Sahmoud, Tarek ;

Noguchi, Shinzaburo ;

Gnant, Michael ;

Pritchard, Kathleen I. ;

Lebrun, Fabienne ;

Beck, J. Thaddeus ;

Ito, Yoshinori ;

Yardley, Denise ;

Deleu, Ines ;

Perez, Alejandra ;

Bachelot, Thomas ;

Vittori, Luc ;

Xu, Zhiying ;

Mukhopadhyay, Pabak ;

Lebwohl, David ;

Hortobagyi, Gabriel N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :520-529

[3] Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer [J].

Baselga, Jose ;

Cortes, Javier ;

Kim, Sung-Bae ;

Im, Seock-Ah ;

Hegg, Roberto ;

Im, Young-Hyuck ;

Roman, Laslo ;

Pedrini, Jose Luiz ;

Pienkowski, Tadeusz ;

Knott, Adam ;

Clark, Emma ;

Benyunes, Mark C. ;

Ross, Graham ;

Swain, Sandra M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :109-119

[4] NATURAL HISTORY OF UNTREATED BREAST CANCER (1805-1933) - COMPARISON OF UNTREATED AND TREATED CASES ACCORDING TO HISTOLOGICAL GRADE OF MALIGNANCY [J].

BLOOM, HJG ;

HARRIES, EJ ;

RICHARDSON, WW .

BRITISH MEDICAL JOURNAL, 1962, (5299) :213-&

[5] Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines? [J].

Bonotto, Marta ;

Gerratana, Lorenzo ;

Iacono, Donatella ;

Minisini, Alessandro Marco ;

Rihawi, Karim ;

Fasola, Gianpiero ;

Puglisi, Fabio .

ONCOLOGIST, 2015, 20 (07) :719-724

[6] Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer [J].

Brennan, M. E. ;

Houssami, N. .

BREAST, 2012, 21 (02) :112-123

[7] ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) [J].

Cardoso, F. ;

Costa, A. ;

Norton, L. ;

Senkus, E. ;

Aapro, M. ;

Andre, F. ;

Barrios, C. H. ;

Bergh, J. ;

Biganzoli, L. ;

Blackwell, K. L. ;

Cardoso, M. J. ;

Cufer, T. ;

El Saghir, N. ;

Fallowfield, L. ;

Fenech, D. ;

Francis, P. ;

Gelmon, K. ;

Giordano, S. H. ;

Gligorov, J. ;

Goldhirsch, A. ;

Harbeck, N. ;

Houssami, N. ;

Hudis, C. ;

Kaufman, B. ;

Krop, I. ;

Kyriakides, S. ;

Lin, U. N. ;

Mayer, M. ;

Merjaver, S. D. ;

Nordstrom, E. B. ;

Pagani, O. ;

Partridge, A. ;

Penault-Llorca, F. ;

Piccart, M. J. ;

Rugo, H. ;

Sledge, G. ;

Thomssen, C. ;

van't Veer, L. ;

Vorobiof, D. ;

Vrieling, C. ;

West, N. ;

Xu, B. ;

Winer, E. .

ANNALS OF ONCOLOGY, 2014, 25 (10) :1871-1888

[8] Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast Cancer [J].

Dawood, Shaheenah ;

Broglio, Kristine ;

Gonzalez-Angulo, Ana M. ;

Buzdar, Aman U. ;

Hortobagyi, Gabriel N. ;

Giordano, Sharon H. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) :4891-4898

[9] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[10]

Fink Kathleen R, 2013, Surg Neurol Int, V4, pS209, DOI 10.4103/2152-7806.111298

← 1 2 3 4 →